{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T21:42:42Z","timestamp":1782078162155,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-023-09521-3","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T21:23:12Z","timestamp":1679865792000},"page":"3617-3626","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Determination of arterial invasion in pancreatic ductal adenocarcinoma: what is the best diagnostic criterion on CT?"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3611-4790","authenticated-orcid":false,"given":"Yoshifumi","family":"Noda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoma","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Kaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuminori","family":"Hyodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash R.","family":"Kambadakone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,10]]},"reference":[{"key":"9521_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7\u201333","journal-title":"CA Cancer J Clin"},{"key":"9521_CR2","doi-asserted-by":"crossref","unstructured":"Kamarajah SK, Burns WR, Frankel TL, Cho CS, Nathan H (2017) Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis. Ann Surg Oncol 24:2023\u20132030","DOI":"10.1245\/s10434-017-5810-x"},{"key":"9521_CR3","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3389\/fonc.2020.01112","volume":"10","author":"F Giovinazzo","year":"2020","unstructured":"Giovinazzo F, Soggiu F, Jang JY et al (2020) Gemcitabine-based neoadjuvant treatment in borderline resectable pancreatic ductal adenocarcinoma: a meta-analysis of individual patient data. Front Oncol 10:1112","journal-title":"Front Oncol"},{"key":"9521_CR4","unstructured":"NCCN clinical practice guidelines in oncology: pancreatic adenocarcinoma, version 2. 2022. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/pancreatic.pdf"},{"key":"9521_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1148\/radiol.13131184","volume":"270","author":"MM Al-Hawary","year":"2014","unstructured":"Al-Hawary MM, Francis IR, Chari ST et al (2014) Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology 270:248\u2013260","journal-title":"Radiology"},{"key":"9521_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.suronc.2020.08.031","volume":"35","author":"M Weniger","year":"2020","unstructured":"Weniger M, Moir J, Damm M et al (2020) Neoadjuvant therapy in elderly patients receiving FOLFIRINOX or gemcitabine\/nab-paclitaxel for borderline resectable or locally advanced pancreatic cancer is feasible and lead to a similar oncological outcome compared to non-aged patients - Results of the RESPECT-Study. Surg Oncol 35:285\u2013297","journal-title":"Surg Oncol"},{"key":"9521_CR7","doi-asserted-by":"crossref","unstructured":"Dendumrongsup T, Plumb AA, Halligan S, Fanshawe TR, Altman DG, Mallett S (2014) Multi-reader multi-case studies using the area under the receiver operator characteristic curve as a measure of diagnostic accuracy: systematic review with a focus on quality of data reporting. PLoS One 9:e116018","DOI":"10.1371\/journal.pone.0116018"},{"key":"9521_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.acra.2006.09.048","volume":"14","author":"L Hadjiiski","year":"2007","unstructured":"Hadjiiski L, Chan HP, Sahiner B, Helvie MA, Roubidoux MA (2007) Quasi-continuous and discrete confidence rating scales for observer performance studies: Effects on ROC analysis. Acad Radiol 14:38\u201348","journal-title":"Acad Radiol"},{"key":"9521_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2021.0149","author":"MN Mavros","year":"2021","unstructured":"Mavros MN, Moris D, Karanicolas PJ, Katz MHG, O\u2019Reilly EM, Pawlik TM (2021) Clinical trials of systemic chemotherapy for resectable pancreatic cancer: a review. JAMA Surg. https:\/\/doi.org\/10.1001\/jamasurg.2021.0149","journal-title":"JAMA Surg"},{"key":"9521_CR10","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.2214\/ajr.168.6.9168704","volume":"168","author":"DS Lu","year":"1997","unstructured":"Lu DS, Reber HA, Krasny RM, Kadell BM, Sayre J (1997) Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR Am J Roentgenol 168:1439\u20131443","journal-title":"AJR Am J Roentgenol"},{"key":"9521_CR11","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.cgh.2008.09.014","volume":"6","author":"JC Wong","year":"2008","unstructured":"Wong JC, Lu DS (2008) Staging of pancreatic adenocarcinoma by imaging studies. Clin Gastroenterol Hepatol 6:1301\u20131308","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9521_CR12","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1148\/radiol.2453061795","volume":"245","author":"GA Zamboni","year":"2007","unstructured":"Zamboni GA, Kruskal JB, Vollmer CM, Baptista J, Callery MP, Raptopoulos VD (2007) Pancreatic adenocarcinoma: value of multidetector CT angiography in preoperative evaluation. Radiology 245:770\u2013778","journal-title":"Radiology"},{"key":"9521_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1148\/radiol.2291020582","volume":"229","author":"JG Fletcher","year":"2003","unstructured":"Fletcher JG, Wiersema MJ, Farrell MA et al (2003) Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. Radiology 229:81\u201390","journal-title":"Radiology"},{"key":"9521_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00330-002-1473-4","volume":"13","author":"C Catalano","year":"2003","unstructured":"Catalano C, Laghi A, Fraioli F et al (2003) Pancreatic carcinoma: the role of high-resolution multislice spiral CT in the diagnosis and assessment of resectability. Eur Radiol 13:149\u2013156","journal-title":"Eur Radiol"},{"key":"9521_CR15","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s00261-004-0279-z","volume":"30","author":"G Karmazanovsky","year":"2005","unstructured":"Karmazanovsky G, Fedorov V, Kubyshkin V, Kotchatkov A (2005) Pancreatic head cancer: accuracy of CT in determination of resectability. Abdom Imaging 30:488\u2013500","journal-title":"Abdom Imaging"},{"key":"9521_CR16","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1148\/radiol.11101189","volume":"259","author":"C Koelblinger","year":"2011","unstructured":"Koelblinger C, Ba-Ssalamah A, Goetzinger P et al (2011) Gadobenate dimeglumine-enhanced 3.0-T MR imaging versus multiphasic 64-detector row CT: prospective evaluation in patients suspected of having pancreatic cancer. Radiology 259:757\u2013766","journal-title":"Radiology"},{"key":"9521_CR17","first-page":"457","volume":"8","author":"WY Zhao","year":"2009","unstructured":"Zhao WY, Luo M, Sun YW et al (2009) Computed tomography in diagnosing vascular invasion in pancreatic and periampullary cancers: a systematic review and meta-analysis. Hepatobiliary Pancreat Dis Int 8:457\u2013464","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"9521_CR18","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1007\/s00432-014-1728-x","volume":"140","author":"R Yang","year":"2014","unstructured":"Yang R, Lu M, Qian X et al (2014) Diagnostic accuracy of EUS and CT of vascular invasion in pancreatic cancer: a systematic review. J Cancer Res Clin Oncol 140:2077\u20132086","journal-title":"J Cancer Res Clin Oncol"},{"key":"9521_CR19","first-page":"75","volume":"19","author":"BC Chapman","year":"2018","unstructured":"Chapman BC, Gleisner A, Rigg D et al (2018) Perioperative and survival outcomes following neoadjuvant FOLFIRINOX versus gemcitabine abraxane in patients with pancreatic adenocarcinoma. JOP 19:75\u201385","journal-title":"JOP"},{"key":"9521_CR20","doi-asserted-by":"publisher","first-page":"615","DOI":"10.2214\/AJR.08.1022","volume":"194","author":"DE Morgan","year":"2010","unstructured":"Morgan DE, Waggoner CN, Canon CL et al (2010) Resectability of pancreatic adenocarcinoma in patients with locally advanced disease downstaged by preoperative therapy: a challenge for MDCT. AJR Am J Roentgenol 194:615\u2013622","journal-title":"AJR Am J Roentgenol"},{"key":"9521_CR21","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1148\/radiol.2502080501","volume":"250","author":"YE Kim","year":"2009","unstructured":"Kim YE, Park MS, Hong HS et al (2009) Effects of neoadjuvant combined chemotherapy and radiation therapy on the CT evaluation of resectability and staging in patients with pancreatic head cancer. Radiology 250:758\u2013765","journal-title":"Radiology"},{"key":"9521_CR22","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1148\/radiol.2018171670","volume":"287","author":"M Zins","year":"2018","unstructured":"Zins M, Matos C, Cassinotto C (2018) Pancreatic adenocarcinoma staging in the era of preoperative chemotherapy and radiation therapy. Radiology 287:374\u2013390","journal-title":"Radiology"},{"key":"9521_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/SLA.0000000000003284","volume":"273","author":"MJ Truty","year":"2021","unstructured":"Truty MJ, Kendrick ML, Nagorney DM et al (2021) Factors predicting response, perioperative outcomes, and survival following total neoadjuvant therapy for borderline\/locally advanced pancreatic cancer. Ann Surg 273:341\u2013349","journal-title":"Ann Surg"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-09521-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-023-09521-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-09521-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T12:15:07Z","timestamp":1682079307000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-023-09521-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["9521"],"URL":"https:\/\/doi.org\/10.1007\/s00330-023-09521-3","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,10]]},"assertion":[{"value":"10 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Yoshifumi Noda.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"AK: Grant support for research activities from Philips, GE Healthcare, and PanCAN. Other authors report no relevant disclosures or conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived because this is a retrospective study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"<i>\u2022<\/i> retrospective<i>\u2022<\/i> diagnostic or prognostic study<i>\u2022<\/i> performed at one institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}